Journal of Young Pharmacists,
Год журнала:
2021,
Номер
13(3s), С. s84 - s88
Опубликована: Дек. 8, 2021
Introduction:
A
bibliometric
assessment
of
coronavirus
disease
2019
(Covid-19)-related
thyroid
research
is
unavailable.
Materials
and
Methods:
We
searched
Elsevier’s
Scopus
database
for
publications
on
Covid-19
up
to
August
18,
2021,
using
a
predefined
search
strategy.
The
data
were
analyzed
by
publication
characteristics,
the
most
active
countries,
institutions,
authors,
journals,
citations,
trends.
Results:
global
totaled
599;
446
(74.4%)
original
articles.
Only
18.0%
(108)
funded,
but
these
received
higher
citations
per
paper
(CPP)
than
non-funded
(average
CPP
14.8
versus
9.8).
Of
97
countries
that
participated
in
research,
USA,
Italy,
India,
China
productive,
whereas
China,
Germany,
UK,
USA
impactful.
studied
patient
population
groups
“Adults”
(50.5%),
“Middle-Aged”
(33.7%),
“Aged”
(29.3%),
“Children”
(7.8%),
“Adolescents”
(6.5%).
organizations
authors
numbered
272
404,
respectively.
productive
Universita
Degli
Studi
Napoli,
Harvard
Medical
School,
Milano,
Italy.
G.
Troncone,
L.
Glovanella,
Anedda.
top
journals
Endocrine,
Journal
Endocrine
Investigation,
Frontiers
Endocrinology.
22
(3.6%)
highly-cited
141.8).
Conclusion:
concerning
disorders
has
been
largely
conducted
Europe
with
contributions
from
India.
There
need
foster
collaboration
between
high-
low-income
formulating
better
strategies
tackle
thyroidrelated
morbidities
Covid-19.
Additionally,
such
should
involve
younger
age
groups.
justify;">Key
words:
Coronavirus
2019,
Thyroid
diseases,
Co-morbidities,
Children,
Adults.
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Апрель 18, 2023
The
coronavirus
disease
19
(COVID-19)
pandemic
has
prompted
the
development
of
new
vaccines
to
reduce
morbidity
and
mortality
associated
with
this
disease.
Recognition
report
potential
adverse
effects
these
novel
(especially
urgent
life-threatening
ones)
is
therefore
essential.A
16-year-old
boy
presented
Paediatric
Emergency
Department
polyuria,
polydipsia
weight
loss
over
last
four
months.
His
past
medical
history
was
unremarkable.
Onset
symptoms
referred
be
few
days
after
first
dose
anti-COVID-19
BNT162b2
Comirnaty
vaccine
then
worsened
second
dose.
physical
exam
normal,
without
neurological
abnormalities.
Auxological
parameters
were
within
normal
limits.
Daily
fluid
balance
monitoring
confirmed
polyuria
polydipsia.
Biochemistry
laboratory
analysis
urine
culture
normal.
Serum
osmolality
297
mOsm/Kg
H2O
(285-305),
whereas
80
(100-1100),
suggesting
diabetes
insipidus.
Anterior
pituitary
function
preserved.
Since
parents
refused
give
consent
water
deprivation
test,
treatment
Desmopressin
administered
ex
juvantibus
diagnosis
AVP
deficiency
(or
central
insipidus).
Brain
MRI
revealed
stalk
thickening
(4
mm)
contrast
enhancement,
posterior
bright
spot
on
T1
weighted
imaging.
Those
signs
consistent
neuroinfundibulohypophysitis.
Immunoglobulin
levels
Low
doses
oral
sufficient
control
patient's
symptoms,
normalizing
serum
urinary
values
daily
at
discharge.
2
months
showed
stable
thicken
still
undetectable
pituitary.
Due
persistence
polydipsia,
therapy
adjusted
by
increasing
dosage
number
administrations.
Clinical
neuroradiological
follow-up
ongoing.Hypophysitis
a
rare
disorder
characterized
lymphocytic,
granulomatous,
plasmacytic,
or
xanthomatous
infiltration
gland
stalk.
Common
manifestations
are
headache,
hypopituitarism,
To
date,
only
time
correlation
between
SARS-CoV-2
infection
hypophysitis
subsequent
hypopituitarism
been
reported.
Further
studies
will
needed
deepen
possible
causal
link
deficiency.
To
improve
medical
care
and
rehabilitation
algorithms
for
patients
affected
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
it
is
important
to
evaluate
summarize
the
available
data
on
effect
of
infection
(COVID-19)
endocrine
system.
The
purpose
this
review
was
study
COVID-19
scientific
novelty
evaluation
system
potential
hormones
susceptibility
COVID-19.
results
show
that
vulnerable
disorders
caused
COVID-19,
mainly
thyroid
dysfunction
hyperglycemia.
information
in
published
literature
mentioned
here
contains
some
unclear
aspects
contradictory
data,
but
much
remains
be
studied
clarified
regarding
impact
In
particular,
concerns
hyperglycemic
status
who
have
had
infection,
which
extremely
future
metabolic
health
survivors.
This
contributes
discourse
systematically
synthesizing
disparate
studies
identify
patterns,
gaps,
emerging
trends
concerning
effects
By
integrating
these
findings,
offers
a
novel
perspective
hormonal
interactions
influencing
outcomes,
proposing
new
hypotheses
frameworks
research.
Frontiers in Endocrinology,
Год журнала:
2022,
Номер
13
Опубликована: Июнь 10, 2022
SARS-CoV-2
infection,
responsible
for
the
coronavirus
disease
2019
(COVID-19),
can
impair
any
organ
system
including
endocrine
glands.
However,
hypothalamic–pituitary
dysfunctions
following
infection
remain
largely
unexplored.
We
described
a
case
of
hypothalamic
amenorrhea
in
36-year-old
healthy
woman.
The
diagnostic
workup
excluded
all
causes
secondary
amenorrhea,
agreement
to
current
guidelines,
whereas
gonadotropin
increase
response
GnRH
analogue
tests
was
suggestive
impairment.
Therefore,
since
our
patient
did
not
present
organic
cause
disorder,
we
hypothesized
that
her
deficiency
may
have
been
consequence
infection.
This
assumption,
besides
on
temporal
consecutio,
is
strengthened
by
fact
circuits,
altering
axes,
given
angiotensin-converting
enzyme
2
receptors
also
observed
hypothalamus.
reviewed
literature
regarding
dysfunction
patients
with
No
study
has
previously
female
hypogonadotropic
hypogonadism
COVID-19.
suggest
clinicians
focusing
greater
attention
this
possible
disorder.
BioScience Trends,
Год журнала:
2023,
Номер
17(2), С. 85 - 116
Опубликована: Март 13, 2023
Over
three
years
have
passed
since
the
COVID-19
pandemic
started.
The
dangerousness
and
impact
of
should
definitely
not
be
ignored
or
underestimated.
Other
than
symptoms
acute
infection,
long-term
associated
with
SARS-CoV-2
which
are
referred
to
here
as
"sequelae
long
COVID
(LC)",
also
a
conspicuous
global
public
health
concern.
Although
such
sequelae
were
well-documented,
understanding
insights
regarding
LC-related
remain
inadequate
due
limitations
previous
studies
(the
follow-up,
methodological
flaws,
heterogeneity
among
studies,
etc.).
Notably,
robust
evidence
diagnosis
treatment
certain
LC
insufficient
has
been
stumbling
block
better
management
these
patients.
This
awkward
situation
motivated
us
conduct
this
review.
Here,
we
comprehensively
reviewed
updated
information,
particularly
focusing
on
clinical
issues.
We
attempt
provide
latest
information
by
systematically
reviewing
involvement
main
organ
systems.
propose
paths
for
future
exploration
based
available
knowledge
authors'
experience.
believe
that
take-home
messages
will
helpful
gain
into
ultimately
benefit
practice
in
treating
sequelae.
European Journal of Endocrinology,
Год журнала:
2022,
Номер
187(3), С. K19 - K25
Опубликована: Июнь 27, 2022
Since
the
outbreak
of
COVID-19
pandemic,
several
cases
pituitary
apoplexy
(PA)
following
a
SARS-CoV-2
infection
have
been
described
in
countries.
Here,
we
describe
case
series
PA
occurring
aftermath
to
alert
physicians
about
possible
neuro-endocrinological
damage
caused
by
virus
that
can
lead
visual
sequelae
and
hypopituitarism.We
retrospectively
identified
all
adult
patients
treated
at
Amiens
University
Hospital
between
March
2020
May
2021
for
confirmed
cerebral
imaging
an
RT-PCR-confirmed
infection.Eight
(six
women,
two
men)
occurred
were
reviewed
this
study.
The
mean
age
diagnosis
was
67.5
±
9.8
years.
Only
one
patient
had
'known'
non-functional
macroadenoma.
most
common
symptom
sudden
headache.
Brain
typical
cases.
required
decompression
surgery,
whereas
others
managed
conservatively.
clinical
outcome
favorable
but
without
recovery
their
deficiencies.
There
no
diabetes
insipidus.This
series,
largest
literature,
reinforces
strength,
consistency,
coherence
association
PA.
Our
study
provides
support
hypothesis
may
be
new
precipitating
factor
It
is
essential
practitioners
alerted
disease
due
so
such
are
recognized
appropriately
managed,
hence
improving
prognosis.
Biomedicines,
Год журнала:
2022,
Номер
10(11), С. 2855 - 2855
Опубликована: Ноя. 8, 2022
This
review
is
aimed
at
illustrating
and
discussing
the
neuroimmune
endocrinological
aspects
of
SARS-CoV-2
infection
in
light
studies
on
this
topic
that
have
so
far
appeared
literature.
The
most
characteristic
findings
pending
controversies
were
derived
by
PubMed
Scopus
databases.
We
included
original
observational
studies,
reviews,
meta-analysis,
case
reports.
entry
coronavirus
into
susceptible
cells
allowed
interaction
with
an
ecto-enzyme
located
human
cells,
angiotensin-converting
enzyme
2
(ACE2).
also
targets
central
nervous
system
(CNS),
including
hypothalamic-pituitary
structures,
as
their
tissues
express
ACE2,
ACE2
mRNA
expression
hypothalamus
pituitary
gland
has
been
confirmed
autoptic
study
patients
who
died
COVID
19.
may
cause
endocrine
disorders
acute
phase
post-COVID
period,
particularly
due
to
effects
virus
CNS
level
involving
axis.
aggression
hypothalamus-pituitary
region
elicit
autoimmune
process
axis,
responsible
consequently
for
functional
satellite
glands.
Adrenal,
thyroid
gonadal
dysfunctions,
well
alterations
GH
prolactin
secretions,
reported.
However,
extent
which
COVID-19
contributes
short-
long-term
currently
being
discussed
deserves
further
detailed
research.
Egyptian journal of Immunology,
Год журнала:
2023,
Номер
30(1), С. 73 - 86
Опубликована: Янв. 1, 2023
The
worldwide
medical
systems
are
still
being
severely
impacted
by
the
coronavirus
disease-2019
(COVID-19)
pandemic,
which
is
responsible
for
catastrophic
mortality
and
morbidity.
It
becomes
more
obvious
that
this
unique
respiratory
virus's
impacts
go
beyond
system
as
time
goes
on
our
comprehension
of
it
deepens.
transmembrane
serine
protease
2
(TMPRSS2)
protein
necessary
severe
acute
syndrome
2,
cause
COVID-19,
to
gain
cellular
entry
through
angiotensin-converting
enzyme
(ACE2)
receptor.
Most
endocrine
glands
exhibit
high
levels
expression
ACE2
TMPRSS2.
This
pays
attention
effect
COVID-19
system.
Besides
its
capability
pass
central
nervous
especially
hypothalamus
inducing
a
lot
functional
disorders
in
individuals.
Although
effective
vaccines
became
widely
available,
declined
but
shifting
lengthy
health
survivors.
To
inform
suitable
research
management,
review
provides
an
overview
data
examining
besides
hypothalamus.
In
addition,
we
reported
if
endocrinal
thalamic
could
affect
incidence
progress
COVID-19.